Brain+ ApS
Brain+ A/S, a healthtech company, develops and commercializes technology solutions in dementia care primarily for cognitive stimulation therapy. The company is developing Ayla, a scalable dementia care platform that offers practical, human-centered, and clinically proven software-based dementia therapy and care solutions. It is also developing Ayla " your CST Assistant, a software-based dementia … Read more
Brain+ ApS (BRAINP) - Total Liabilities
Latest total liabilities as of June 2025: Dkr20.90 Million DKK
Based on the latest financial reports, Brain+ ApS (BRAINP) has total liabilities worth Dkr20.90 Million DKK as of June 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Brain+ ApS - Total Liabilities Trend (2015–2024)
This chart illustrates how Brain+ ApS's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Brain+ ApS Competitors by Total Liabilities
The table below lists competitors of Brain+ ApS ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
GCM RESOURCES
MU:LFD
|
Germany | €6.85 Million |
|
Comptoir Group PLC
LSE:COM
|
UK | GBX28.62 Million |
|
Cupani Metals Corp.
PINK:ICPLF
|
USA | $685.91K |
|
United Oil & Gas Plc
LSE:UOG
|
UK | GBX1.38 Million |
Liability Composition Analysis (2015–2024)
This chart breaks down Brain+ ApS's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.80 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.45 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.59 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Brain+ ApS's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Brain+ ApS (2015–2024)
The table below shows the annual total liabilities of Brain+ ApS from 2015 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | Dkr22.15 Million | -6.08% |
| 2023-12-31 | Dkr23.59 Million | -18.64% |
| 2022-12-31 | Dkr28.99 Million | +10.31% |
| 2021-12-31 | Dkr26.28 Million | -6.05% |
| 2020-12-31 | Dkr27.97 Million | +35.70% |
| 2019-12-31 | Dkr20.61 Million | +24.67% |
| 2018-12-31 | Dkr16.53 Million | +73.13% |
| 2017-12-31 | Dkr9.55 Million | +88.51% |
| 2016-12-31 | Dkr5.07 Million | +91.33% |
| 2015-12-31 | Dkr2.65 Million | -- |